three β-subunit types have been identified. Different α-subunits can combine with different β-subunits to form bioactive Na + ,K + -ATPase. Although the α-subunit is the catalytic subunit of Na + ,K + -ATPase, its assembly with a β-subunit in the endoplasmic reticulum is a prerequisite for stable expression, full function and transport to the cell membrane (Geering, 1990; McDonough et al, 1990) .
The Na + ,K + -ATPase generated electrochemical gradient is responsible for transport of several compounds over the cell membrane. The uptake of cisplatin, a chemotherapeutic agent that has been used in the treatment of hormone-refractory prostate cancer (Akimoto et al, 1994; Coughlin et al, 1994; Sakai et al, 1994; Veronesi et al, 1996) , is also regulated in a number of cell systems by Na + ,K + -ATPase. Andrews et al. (1991) describe the inhibition of cisplatin uptake by treatment of ovarian carcinoma cells with ouabain, a specific inhibitor of Na + ,K + -ATPase activity. Shinohara et al (1994) reported that low levels of Na + ,K + -ATPase would protect NIH/3T3 cells against cisplatin-induced apoptosis. Furthermore, a link was made between low levels of expression of Na + ,K + -ATPase and insensitivity to cisplatin in non-small-cell lung cancer cells (Ohmori et al, 1994; Kasahara et al, 1996; Bando et al, 1997) . Bando et al (1998a Bando et al ( , 1998b , however, reported that in small-cell lung cancer cells this correlation could not be made.
In search for genes that are potentially involved in the transition from hormone-dependent to hormone-independent prostate cancer cell growth, the β1-subunit of Na + ,K + -ATPase was identified. In the current study it is shown that expression of the β1-subunit of Na + ,K + -ATPase is increased in hormone-independent human prostate cancer xenografts. Furthermore, it is shown that androgens are potent inhibitors of Na + ,K + -ATPase activity in androgendependent prostate cancer cells.
A problem in the treatment of prostate cancer is that 50% of men, treated for what seemed to be confined prostate cancer, actually already have advanced prostate cancer. Advanced prostate cancer can initially be treated effectively by androgen ablation therapy, but eventually will evolve into androgen-independent prostate cancer. The reason metastatic disease can develop is that the initial treatment of prostate cancer was not effective in removing (surgery) or destroying (irradiation) all prostate cancer cells. At this moment much attention is drawn to develop adjuvant treatment modules to remove cancer cells remaining after the initial treatment (Schnidt et al, 1993; Oliver and Gallagher, 1995; Nelson and Simons, 1996; Chao et al, 1997 ).
In the current study, investigations were also performed to test the hypothesis that decreased Na + ,K Summary The β1-subunit of Na + ,K + -ATPase was isolated and identified as an androgen down-regulated gene. Expression was observed at high levels in androgen-independent as compared to androgen-dependent (responsive) human prostate cancer cell lines and xenografts when grown in the presence of androgens. Down-regulation of the β1-subunit was initiated at concentrations between 0.01 nM and 0.03 nM of the synthetic androgen R1881 after relatively long incubation times (> 24 h). Using polyclonal antibodies, the concentration of β1-subunit protein, but not of the α1-subunit protein, was markedly reduced in androgen-dependent human prostate cancer cells (LNCaP-FGC) cultured in the presence of androgens. In line with these observations it was found that the protein expression of total Na + ,K + -ATPase in the membrane (measured by 3 H-ouabain binding) was also markedly decreased. The main function of Na + ,K + -ATPase is to maintain sodium and potassium homeostasis in animal cells. The resulting electrochemical gradient is facilitative for transport of several compounds over the cell membrane (for example cisplatin, a chemotherapeutic agent experimentally used in the treatment of hormone-refractory prostate cancer). Here we observed that a ouabain-induced decrease of Na + ,K + -ATPase activity in LNCaP-FGC cells results in reduced sensitivity of these cells to cisplatin-treatment. Surprisingly, androgen-induced decrease of Na + ,K activity in prostate cancer cells would result in reduced sensitivity to cisplatin treatment. The latter investigations may be relevant for improving the effectiveness of treatment of prostate cancer using chemotherapeutic agents.
MATERIALS AND METHODS

Cells
The LNCaP-FGC cell line is a gift from Dr JS Horoszewicz (Buffalo, NY, USA) and is identical to the LNCaP cell line which is provided by ATCC (Horoszewicz et al, 1983 
Human prostate cancer xenografts
Tumour specimens, obtained from primary carcinomas, metastatic lesions and transurethral resection, were implanted subcutaneously (s.c.) into both shoulders of NMRI male nude mice. All animals had been castrated and supplemented with testosterone before surgery, in order to ensure a similar endocrine background for all tumours. The human prostate cancer xenograft panel used for these investigations contained four androgen-responsive and five androgen-independent tumours . Among the androgen-responsive human prostate cancer xenografts, three xenografts (PC-82, PC-295 and PC-310) are fully dependent on androgens for growth, while one xenograft (PC-346) shows a heterogeneous response when androgens are withdrawn from the tumour-bearing mice. The tumours retained their resemblance to the original patient material, and their main characteristics have been described (van Weerden et al, 1996) .
Differential display PCR
Differential display polymerase chain reaction (ddPCR) was originally performed to detect differences in mRNA expression between the androgen-dependent LNCaP-FGC prostate cancer cell line and the androgen-independent LNCaP-LNO cell line. As outlined in detail by Chang et al (1997) , R1881 and vitamin D 3 were added in order to obtain similar growth characteristics in both cell lines. LNCaP-FGC and LNCaP-LNO cells were cultured for 6 days in the presence or absence of R1881 (0.1 nM, 10 nM), vitamin D 3 (100 nM) or a combination of the two hormones (10 nM R1881 + 100 nM vitamin D 3 ). The biologically active vitamin D metabolite 1,25(OH) 2 D 3 was a gift from Dr L Binderup (Leo Pharmaceutical Products, Ballerup, Denmark) and was donated to us by Dr JPTM van Leeuwen (Department of Internal Medicine, Erasmus University Rotterdam, The Netherlands). Total RNA was isolated and using a random primer (5′-GCAAGCTTGCTA-CAACGAGG-3′ [Pharmacia Biotech, Roosendaal, The Netherlands]) cDNA was generated (MMLV-reverse transcriptase; Life Technologies, Breda, The Netherlands). The cDNA was used in a PCR reaction (Super Taq, Biotechnology Ltd, Cambridge, UK) using the same primer in the forward and reverse reaction in the presence of 32 P-dATP (Amersham, Buckinghamshire, UK). Further details are described by Chang et al (1997) .
RNA isolation and hybridization
Total RNA was isolated and electrophoresed as described by Blok et al (1995) . As a probe to detect the β1-subunit of Na + ,K + -ATPase, a 191 bp differential display PCR-fragment was used. For PSA mRNA detection, a previously isolated 266 bp differential display PCR-fragment (Blok et al, 1995) was used. The β-actin probe represents a 1.1 kb Pst1-fragment from hamster β-actin.
Western blot
LNCaP-FGC cells were cultured in RPMI-1640 + 5% dcc-FCS in the presence or absence of 0.1 nM R1881. Subsequently, the cells were lysed and equal amounts of protein were loaded onto a sodium dodecyl sulphate (SDS)-containing polyacrylamide gel, electrophoresed and blotted onto nitrocellulose. A goat polyclonal antibody raised against rabbit α1Ðβ1 Na 
Ouabain binding analysis
LNCaP-FGC cells were cultured to 50% confluence in RPMI-1640 + 5% dcc-FCS in the presence or absence of 0.1 nM R1881. After 3 days the medium was renewed and after 6 days the medium was changed for incubation buffer (40 mM imidazole, pH 7.3, 250 mM sucrose, 5 mM magnesium chloride) containing different amounts of 3 H-ouabain (2.5 nM, 5 nM, 10 nM, 20 nM, 40 nM, 80 nM) in the presence or absence of 500-fold non-labelled ouabain.
3 H-ouabain was obtained from Amersham. The cells were incubated with 3 H-ouabain for 2 h at 37°C. Subsequently, the cells were washed four times with incubation buffer at 0°C, before being lysed in 0.5 M sodium hydroxide (NaOH) for 45 min at 56°C. Samples (50 µl) were counted using liquid scintillation and protein concentrations were measured using BradfordÕs reagent. Scatchard plots were constructed and K d and B max values calculated.
Ouabain/cisplatin incubations
Toxicity of ouabain was measured, after 8 days of culture in a 12-well tissue culture plate in the presence of different concentrations of ouabain, by incubating the cells for 30 min at 37°C with nitro blue tetrazolium (NBT; Sigma) (100 mM phosphate pH 7.4, 0.2 mg ml Ð1 NBT, 0.4 mg ml Ð1 NADH). Mitochondrial diaphorase in cells with ruptured membranes will reduce NBT to NBTH 2 , a blue-coloured precipitate.
Toxicity of cisplatin was measured after 8 days of culture (which was found to be an optimal time point) of the LNCaP-FGC cells in the presence or absence of different concentrations of cisplatin. Cells were washed once in phosphate-buffered saline (PBS) to remove dead cells and debris. Subsequently, the cells were lysed in 1 M NaOH for 45 min at 56°C and DNA concentrations were measured (Chang et al, 1997) . In order to determine whether LNCaP-FGC cell death has characteristics of apoptosis or necrosis when exposed to cisplatin, staining of DNA with Hoechst 33342 and propidium iodide (PI) was performed (Darzynkiewicz et al, 1994) . Hoechst 33342 can enter living cells and stain the DNA blue when exposed to 352 nm light. In apoptotic cells the condensed chromatin stains very intense. PI can only stain the DNA of cells with disrupted cellular (plasma and nuclear) membranes. Using this dye, DNA stains red when exposed to 530 nm light. In early apoptotic cells, PI cannot enter the cell, in contrast to late apoptotic cells where the cellular membrane is no longer intact and PI stains the condensed chromatin very intensely. When a cell is necrotic, both Hoechst 33342 and propidium iodide will enter the cell and stain DNA. However, in necrotic cells, the chromatin is not condensed and will only stain diffusely blue and red using Hoechst 33342 and PI respectively (Darzynkiewicz et al, 1994) . This method, to make a distinction between apoptotic and necrotic cells after cisplatin treatment, was also used by Lieberthal et al (1996) . Ruiz et al, 1995) . When mRNA expression of the β1-subunit of Na + ,K + -ATPase was analysed on Northern blots in order to verify the ddPCR results, it was observed that under control culture conditions (no hormones added) the expression levels in LNCaP-FGC and LNCaP-LNO cell lines were similar. However, when hormones were added, the β1-subunit of Na + ,K + -ATPase was found to be markedly downregulated by androgens (0.1 nM and 10 nM R1881) and by vitamin D 3 (100 nM). Furthermore, androgen-induced down-regulation of mRNA expression of the β1-subunit of Na + ,K + -ATPase in the androgen-dependent LNCaP-FGC cells was much more pronounced than in androgen-independent LNCaP-LNO cells (Figure 1) .
RESULTS
Differential expression of the
In human prostate cancer xenografts (grown in testosteronesupplemented castrated nude mice) the expression of the β1-subunit of Na + ,K + -ATPase mRNA was low in the four androgen-responsive xenografts . Interestingly, in four out of five androgen-independent xenografts (PC-133, PC-324, PC-339 and PC-374), the expression of β1-subunit mRNA was markedly higher (Figure 2) . For unknown reasons, the androgen-independent xenograft PC-135 forms an exception because of its low β1-subunit mRNA expression. As indicated, the xenografts were grown in the presence of testosterone and the findings correlate well with the observed differential expression of the β1-subunit between LNCaP-FGC and LNCaP-LNO cells when these cells were cultured in the presence of androgens (Figure 1 , compare LNCaP-FGC lanes 2 and 3 with LNCaP-LNO lanes 2 and 3). A correlation was also observed between the expression of β1-subunit of Na + ,K + -ATPase and glandular differentiation of the xenografts; glandular differentiation of the androgen-responsive xenografts varies from well to moderately-well with the expression of the β1-subunit being low, and glandular differentiation of the androgen-independent xenografts ranges from moderate to poor while the expression of the β1-subunit is high (Figure 2) . The androgen-responsive PC-346 is an exception having low β1-subunit mRNA expression and poor glandular differentiation. + -ATPase in androgen-responsive and androgen-independent human prostate cancer xenografts. Xenografts were dissected from mice and immediately frozen in liquid nitrogen. Total RNA was isolated and loaded on a denaturing gel (20 µg per lane), electrophoresed, blotted and hybridized to the β1-subunit of Na + ,K + -ATPase. Ethidium bromide staining of the RNA revealed that there were no differences in loading of the RNA samples. The xenografts were scored for androgen-responsive (yes) or androgen-independent growth (no), and for degree of glandular differentiation (++ = well; + = moderately-well; +/-= moderate; -= poor; + and -= both moderately-well and poorly differentiated glandular tissue in one xenograft) (van Weerden et al, 1996) Figure 3 Time course of androgen-induced down-regulation of β1-subunit of Na + ,K + -ATPase mRNA expression. LNCaP-FGC cells were cultured for 0-96 h in the absence or presence of 0.1 nM R1881. Total RNA, isolated as indicated in Materials and Methods, was loaded on a denaturing gel (20 µg) and electrophoresed, blotted and hybridized to the β1-subunit of Na + ,K + -ATPase or hamster β-actin. This experiment has been repeated three times producing similar results Cardiac glycosides like ouabain cannot enter cells. Their action on Na + ,K + -ATPase activity can only occur because these compounds bind with a relatively high specificity to the extracellular domain of the α-subunit which is stabilized in the membrane by the β-subunit (Charlemagne, 1993; Mercer, 1993) . Ouabain H-ouabain binding to Na + ,K + -ATPases expressed in the membrane, LNCaP-FGC cells were cultured to 50% confluence in the presence (v) or absence (q) of 0.1 nM R1881. After 6 days the medium was replaced for incubation buffer containing binding will result in decreased activity of Na + ,K + -ATPase. However, radioactively labelled ouabain can also be used to measure the amount of Na In contrast to ouabain-induced inhibition of Na + ,K + -ATPase, androgen-induced down-regulation of Na + ,K + -ATPase does not result in protection against cisplatin-induced prostate cancer cell death. (A) Cells were cultured for 8 days in the presence of different concentrations (0, 0.025, 0.05, 0.1, 0.25, 0.5 and 1 µM) of the specific inhibitor of Na + ,K + -ATPase, ouabain. Cell viability was measured using the NBT assay, as described in Materials and Methods (panel A). (B) LNCaP-FGC cells were cultured for 2 h in the absence (black bars) or presence (shaded bars) of 100 nM ouabain before different concentrations cisplatin were added to the culture medium (0, 20, 30, 35, 40, 45, 50 and 60 µM) . After 8 days the cells were harvested and DNA measured as indicated in the Materials and Methods section (panel B). (C) LNCaP-FGC cells were cultured for 6 days in the absence (black bars) or presence (shaded bars) of 0.1 nM R1881. Subsequently different concentrations cisplatin were added to the culture medium (0, 20, 30, 35, 40, 45, 50 and 60 µM) , and culture was continued for 8 days. Cells were harvested and DNA was measured as indicated in the Materials and Methods section (panel C). These experiments were repeated at least twice producing similar results of 500-fold non-labelled ouabain for a short period of time ( Figure 6 ). Scatchard analysis on living cells revealed a K d of 78 nM in the control situation and 91 nM in case of R1881 pretreatment. The B max value of control cells was 4.9 pmol mg Ð1 protein and about fourfold higher than the B max of R1881 pretreated cells (1.2 pmol mg Ð1 protein). These data are in line with the observations described in Figure 5 , and indicate that androgen-induced down-regulation of the β1-subunit protein expression is ratelimiting for the expression of the α,β-heterodimer of Na + ,K + -ATPase at the cell surface (as measured by 3 H-ouabain binding).
Inhibition of cisplatin-induced cell death
Cisplatin induces cell death in most culture systems. It was observed that cisplatin induces apoptosis at 40 µM and 70 µM and induces necrosis at much higher concentrations (500 µM; data not shown). In all further experiments we have used cisplatin at concentrations below 70 µM.
Cisplatin accumulation in the cell is partly dependent on the K + influx; when the K + gradient is steep, cisplatin will enter the cell relatively easy (Andrews et al, 1991) . The K + gradient is generated by Na + ,K + -ATPase, and there are several indications that reduced expression or activity of Na + ,K + -ATPase will result in reduced uptake of cisplatin (Andrews et al, 1991; Shinohara et al, 1994; Ohmori et al, 1994; Kasahara et al, 1996; Bando et al, 1997 Bando et al, , 1998a Bando et al, , 1998b . For prostate cancer the relation between expression or activity of Na + ,K + -ATPase and effectiveness of cisplatin treatment has not been investigated to this point.
One way to inhibit Na + ,K + -ATPase activity specifically is to culture LNCaP-FGC cells in the presence of ouabain. However, the concentration of ouabain should be low because otherwise the Na + /K + homeostasis becomes too severely disrupted and the cells will die. In order to investigate which concentration of ouabain could be used, LNCaP-FGC cells were cultured in the presence of different concentrations of ouabain and cell viability was measured. It was observed that a concentration of 100 nM ouabain would only marginally reduce viability of the cells ( Figure 7A ).
Next, it was observed that LNCaP-FGC cells cultured in the presence of 100 nM ouabain were much more resistant to cisplatininduced apoptosis than control cells at cisplatin concentrations of 20Ð50 µM ( Figure 7B ). The next step was to culture LNCaP-FGC cells in the presence of 0.1 nM R1881 for 6 days (Na + ,K + -ATPase expression becomes reduced), followed by treatment with different concentrations of cisplatin for 1 week. In contrast to the decrease in Na intracellular Na + concentration is an important regulator, the abundance of the subunits can be controlled by transcriptional or post-transcriptional regulation (aldosterone in kidney and thyroid hormone in myocardium) (Hensley et al, 1992; Wheling et al, 1993; Ewart and Klip, 1995; Middleton, 1996) , but it is also possible to regulate activity of the α-subunit by binding of inhibitors as ouabain and bufalin (MacGregor and Walker, 1993) .
Recently, the promoter of the β1-subunit of Na + ,K + -ATPase was shown to contain several mineralocorticoid and glucocorticoid responsive elements (MRE/GRE) (Derfoul et al, 1998) . When a large portion of the promoter region (Ð1141 to +490) was cloned in front of a luciferase reporter gene, profound up-regulation of transcriptional activity was found in the presence of glucocorticoid receptors in CV-1 cells. It is true that androgen receptors and glucocorticoid receptors can bind to similar responsive elements on DNA (Van Dijck et al, 1989) . However, there are also distinct differences between the two receptors which contribute to receptor-selective transcriptional regulation (Rundlett and Miesfeld, 1995; Claessens et al, 1996; Scheller et al, 1998) . It is interesting that, in contrast to the findings of Derfoul et al (1998) , in the current investigations androgens are potent inhibitors of the expression of the β1-subunit of Na + ,K + -ATPase in LNCaP cells. At the basis of the difference in regulation of β1-subunit mRNA expression by glucocorticoid and androgen receptors may be distinct receptor differences, but promoter and cell context (CV-1 vs LNCaP) may also play an important role.
Down-regulation of the β1-subunit of Na + ,K + -ATPase is much more pronounced in the androgen-dependent LNCaP-FGC cells than in androgen-independent LNCaP-LNO cells. In other words, the β1-subunit of Na + , K + -ATPase is expressed at higher levels in androgen-independent LNCaP-LNO cells cultured in the presence of androgens than in androgen-dependent LNCaP-FGC cells cultured under similar conditions. This observation was also done in human prostate cancer xenografts: androgen-independent xenografts express higher levels of the β1-subunit of Na + ,K + -ATPase than androgen-responsive xenografts when grown in the presence of testosterone. The only exception is xenograft PC-135 which seems to express low levels of β1-subunit mRNA. Because of these findings it may be of interest to investigate whether gain of expression of the β1-subunit of Na + ,K + -ATPase can be used as a molecular marker to distinguish between androgen-dependent and androgen-independent prostate cancer cells in biopsy material from patients who have not been treated by androgen ablation therapy. Another point of interest is that chromosomal localization of the β1-subunit of Na + ,K + -ATPase on 1q24Ð25 is in the same region as the putative prostate cancer-susceptibility locus HPC1 (Cooney et al, 1997) .
Cisplatin is a chemotherapeutic agent that has been used experimentally as adjuvant therapy in the treatment of hormone refractory prostate cancer; the effectiveness of this treatment has always been limited (Akimoto et al, 1994; Coughlin et al, 1994; Sakai et al, 1994; Veronesi et al, 1996) . In the current investigation it is shown that the chemotherapeutic effectiveness of cisplatin treatment of a prostate cancer cell line is affected by Na + ,K + -ATPase activity. When Na + ,K + -ATPase activity is reduced using ouabain as a specific inhibitor, the sensitivity to cisplatin-induced cell death is reduced. Surprisingly, when the prostate cancer cells
